Flagship Pioneering, LLC
Follow13F filer, CIK 1400240, CAMBRIDGE, MA
Flagship Pioneering, LLC reported $591,878,313 across 6 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011756
- Period
- 2024-09-30
- Reported value
- $592M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group Flagship Pioneering, LLC
How groups are builtHoldings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-011756, largest first. % of portfolio is the value over $591,878,313, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MRNAMODERNA INC | 4,632,149 | $310M | 52.3% | 0 | Timeline | ||
| FHTXFOGHORN THERAPEUTICS INC | 12,674,120 | $118M | 19.94% | 0 | Timeline | ||
| SANASANA BIOTECHNOLOGY INC | 25,001,856 | $104M | 17.57% | 0 | Timeline | ||
| OMEGA THERAPEUTICS INCOMEGA THERAPEUTICS INC | 29,225,579 | $35.7M | 6.02% | 0 | |||
| SERES THERAPEUTICS INCSERES THERAPEUTICS INC | 23,117,045 | $21.9M | 3.7% | 0 | |||
| SYRSSYROS PHARMACEUTICALS INC COM | 1,293,849 | $2.78M | 0.47% | 0 | Timeline |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-011756 | base | 2024-11-14 | acceptance time not in the bulk data set |